The tissue distribution and pharmacokinetics of [14C]-olorofim following intravenous dosing in the rat
Journal of Antimicrobial Chemotherapy · 2026
DOI: 10.1093/jac/dkag120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Derek Law und 3 weiteren Autor:innen. Beteiligte Einrichtung: F2G Ltd, Alderley Park, Macclesfield SK10 4TF, UK. Hauptthemen laut MEDLINE: Antifungal Agents, Pyrimidines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
To evaluate the penetration of olorofim, a novel antifungal agent into the tissues of the rat. Materials and methods Quantitative whole-body autoradiography was used to assess the distribution and tissue penetration in male and female rats following a single 2-hour IV infusion of [14C]-olorofim.
Results
Radioactivity was rapidly and extensively distributed throughout many tissues in both sexes with maximal concentrations observed soon after start of the infusion. Thereafter radioactivity declined and at 336 h (final timepoint), concentrations of radioactivity in most tissues were below the limit of quantification. The pattern of radioactive distribution was similar at all timepoints with concentrations greatest in liver, kidney cortex, adrenal cortex, abdominal and brown fat; the lowest concentrations were observed in the whole eye and at the bone surface (with levels similar to plasma in bone marrow and uveal tract/retina). Tissue:plasma radioactivity concentration ratios for most tissues were above unity during the period 2.25 to 72 h post-start of infusion. Radioactivity was detected in tissues frequently reported as sites of systemic fungal infections such as the lung, brain, kidney, bone and eye. Pharmacokinetic analyses showed that at early timepoints >75% of circulating radiolabelled material was intact olorofim confirming that olorofim is present in these key tissues at levels similar to or exceeding those seen in plasma.
Conclusions
Olorofim distributes widely into rat tissues including those frequently infected by fungi, indicating its potential to treat systemic fungal infections caused by susceptible species, a finding in agreement with recent clinical reporting from a Phase 2 trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- F2G Ltd, Alderley Park, Macclesfield SK10 4TF, UK.
- F2G Consultant, Hertfordshire, UK.
Zitieren
APA
Law, D., Ayrton, J., Kennedy, A., & Cornelissen, K. (2026). The tissue distribution and pharmacokinetics of [14C]-olorofim following intravenous dosing in the rat. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag120
Vancouver
Law D, Ayrton J, Kennedy A, Cornelissen K. The tissue distribution and pharmacokinetics of [14C]-olorofim following intravenous dosing in the rat. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag120
BibTeX
@article{Law2026,
author = {Law, Derek and Ayrton, John and Kennedy, Anthony and Cornelissen, Karen},
title = {The tissue distribution and pharmacokinetics of [14C]-olorofim following intravenous dosing in the rat},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
doi = {10.1093/jac/dkag120}
}
EUVIMED